Ichiro Kinoshita

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations

Medicine, Oncology, Pharmacology +13

Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba et al. · Nature Immunology · 2012 · 827 citations · Full text

Medicine, Immunology, Oncology +15

B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

Jun Konishi, Koichi Yamazaki, Miyuki Azuma et al. · Clinical Cancer Research · 2004 · 673 citations

Medicine, Immunology, Oncology +14

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 554 citations

Medicine, Oncology, Pharmacology +15

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Masahisa Jinushi, Shigeki Chiba, Hironori Yoshiyama et al. · Proceedings of the National Academy of Sciences · 2011 · 484 citations · Full text

Medicine, Cancer Biology, Oncology +17